Clinical Trial Update: Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update assessing whether high-dose pitavastatin improves glucose control in patients with metabolic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Pitavastatin (Pitavastatin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Metabolic Syndrome | Phase 4 | Status: UNKNOWN